News | October 24, 2006

Siemens Medical Solutions announced today that the FDA has approved premarket approval (PMA) application for its syngo Lung computer-aided detection (CAD) software, which is designed to assist radiologists in the detection of solid lung nodules in computed tomography (CT) examinations of the chest.
syngo Lung CAD was validated on the use of CAD in thoracic CT examinations in the largest multi-center, multi-reader study performed to date. 17 radiologists using data from four leading medical centers in the U.S. reviewed nearly 200 cases. In each case, the use of syngo Lung CAD as a second reader helped all participating radiologists to significantly increase their detection accuracy for clinically significant lung nodules.


Additional Content

News | Radiology Business

June 6, 2023 — RaySearch Laboratories has announced that New York University (NYU) Langone Hospital - Long Island ...

Time June 06, 2023
arrow
News | Radiology Business

January 18, 2023 — Addressing the growing demand for medical imaging and a shortage of radiologists, Bayer announced the ...

Time January 18, 2023
arrow
News | Artificial Intelligence

December 14, 2022 — Dallas, TX-based MedCognetics, Inc. announced it has received U.S Food and Drug Administration (FDA) ...

Time December 14, 2022
arrow
News | Breast Imaging

November 25, 2022 — Hologic, Inc. will exhibit its extensive portfolio of breast and skeletal health products at the ...

Time November 25, 2022
arrow
News | Digital Pathology

September 13, 2022 — Deciphex, a Dublin, Ireland-based provider of digital pathology software and services, has ...

Time September 13, 2022
arrow
Subscribe Now